A global road map is needed for vaccine research, development, and deployment

Health Affairs

Volumn 30, Issue 6, 2011, Pages 1034-1041

  Mahmoud, Adel ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; SMALLPOX VACCINE; VACCINE; WART VIRUS VACCINE;

ARTICLE; CHOLERA; DRUG EFFICACY; DRUG RESEARCH; HEPATITIS B; HUMAN; MENINGOCOCCOSIS; PNEUMOCOCCAL INFECTION; PNEUMONIA; POLIOMYELITIS; RABIES; SMALLPOX; TETANUS; VACCINATION;

BIOMEDICAL RESEARCH; DEVELOPING COUNTRIES; DRUG APPROVAL; INTERNATIONALITY; RESEARCH; VACCINES;

EID: 79959510613     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0391     Document Type: Article

References (34)

1. Mahmoud A, Levin M. Vaccines at the turn of the 21st century: a new era for immunization in public health. Int J Infect Dis. 2007; 11(Suppl 2):S1-2.
2. Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59(9): 258-61.
3. Centers for Disease Control and Prevention. Updated recommendations for use of meningococcal conjugate vaccines-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2011;60(3):72-6.
4. Clark HF, Offit PA, Plotkin SA, Heaton PM. The new pentavalent rotavirus vaccine composed of bovine (strain WC3)-human rotavirus reassortants. Pediatr Infect Dis J. 2006;25(7):577-83.
5. Bernstein DI. Live attenuated human rotavirus vaccine, Rotarix. Semin Pediatr Infect Dis. 2006;17(4): 188-94.
6. Shi L, Sings HL, Bryan JT, Wang B, Wang Y, Mach H, et al. GARDASIL: prophylactic human papillomavirus vaccine development-from bench top to bed-side. Clin Pharmacol Ther. 2007;81(2):259-64.
7. Schwarz TF. Clinical update of the AS04-adjuvanted human papillomavirus- 16/18 cervical cancer vaccine, Cervarix. Adv Ther. 2009;26(11): 983-98.
8. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebocontrolled trial. Lancet. 2009; 374(9702):1694-702.
9. Kimberlin DW, Whitley RJ. Varicellazoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007; 356(13):1338-43.
10. Zepp F, Schmitt HJ, Cleerbout J, Verstraeten T, Schuerman L, Jacquet JM. Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine). Expert Rev Vaccines. 2009;8(6):663-78.
11. Sandberg KI, Andresen S, Bjune G. A new approach to global health institutions? A case study of new vaccine introduction and the formation of the GAVI Alliance. Soc Sci Med. 2010;71(7):1349-56.
12. GAVI Alliance. Phase II (2006-10) [Internet]. Geneva: GAVI; 2011 [cited 2011 May 13]. Available from: http://www.gavialliance.org/vision/strategy/phase2/.
13. Jadhav S, Datla M, Kreeftenberg H, Hendriks J. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries. Vaccine. 2008;26(13):1611-5.
14. International Finance Facility for Immunisation [home page on the Internet]. London: IFFIm; [cited 11 May 13]. Available from: http://www.iff-immunisation.org/.
15. Advance Market Commitments for Vaccines [home page on the Internet]. Geneva: AMC; c2007 [cited 2011 May 26]. Available from: http://www.vaccineamc.org/.
16. World Health Organization. The Initiative for Vaccine Research report 2008-2009. Geneva: WHO; 2010.
17. Plotkin SA. Vaccines: the fourth century. Clin Vaccine Immunol. 2009;16(12):1709-19.
18. Plotkin SA, Plotkin SL. A short history of vaccination. In: Plotkin SA, Ornestein WA, Offit PA, editors. Vaccines. Philadelphia: Elsevier; 2008. p. 1-16.
19. Enders JF, Weller TH, Robbins FC. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science. 1949;109(2822):85-7.
20. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature. 1982;298(5872):347-50.
21. Schiller JT, Frazer IH, Lowy DR. Human papillomavirus vaccines. In: Plotkin SA, Ornestein WA, Offit PA, editors. Vaccines. Philadelphia: Elsevier; 2008. p. 243-258.
22. Mahmoud A. The global vaccination gap. Science. 2004;305(5681):147.
23. Lydon P, Levine R, Makinen M, Brenzel L, Mitchell V, Milstien JB, et al. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability? Vaccine. 2008;26(51):6706-16.
24. Meningitis Vaccine Project. Men-AfriVac successfully introduced at large scale in Africa [Internet]. Ferney-Voltaire (France): The Project; c2003-11 [cited 2011 May 13]. Available from: http://www.meningvax.org/.
25. World Health Organization. Global immunization vision and strategy 2006-2015. Geneva: WHO; c2011 [cited 2011 May 23]. Available from: http://www.who.int/immunization/givs/en/index.html.
26. Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, et al. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ. 2008; 86(1):27-39.
27. United Nations. UN Summit: highlevel plenary meeting of the General Assembly [Internet]. New York (NY): UN; 2010 Sep 20-22 [cited 2011 May 26]. Available from: http://www.un.org/en/mdg/summit2010/.
28. Food and Drug Administration. Vaccines, blood, and biologics [Internet]. Silver Spring (MD): FDA; 2010 [cited 2011 May 3]. Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/default.htm.
29. Naipaul VS. A bend in the river. New York (NY): Vintage International; 1989.
30. GAVI Alliance. Ghana [Internet]. Geneva: GAVI; 2008 [cited 2011 May 13]. Available from: http://www.gavialliance.org/resources/Ghana_GAVI_Alliance_country_fact_sheet_June_2008_ENG.pdf.
31. GAVI Alliance. Viet Nam [Internet]. Geneva: GAVI; 2008 [cited 2011 May 13]. Available from: http://www.gavialliance.org/resources/Viet_Nam_GAVI_Alliance_country_fact_sheet_June_2008_ENG.pdf.
32. Moyo D. Dead aid: why aid is not working and how there is another way for Africa. 1st ed. Toronto: Douglas and Mcintyre Ltd.; 2010.
33. Mahmoud A. Vaccines at crossroads. Global Health Magazine [serial on the Internet]. 2010 Fall [cited 2011 May 26]. Available from: http://www.globalhealthmagazine.com/top_stories/vaccines_at_crossroads.
34. Lederberg J. Infectious history. Science. 2000;288(5464):287-93.